Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
$0.3675
+0.0035 ( +3.52% ) 296.9K
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Market Data
Open
$0.3675
Previous close
$0.3640
Volume
296.9K
Market cap
$3.67M
Day range
$0.3300 - $0.3820
52 week range
$0.2208 - $2.2700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 16, 2024 |
8-k | 8K-related | 13 | Nov 21, 2024 |
10-q | Quarterly Reports | 86 | Nov 13, 2024 |
def | Proxies and info statements | 4 | Oct 25, 2024 |
ars | Annual reports | 1 | Oct 25, 2024 |
8-k | 8K-related | 14 | Oct 18, 2024 |
8-k | 8K-related | 15 | Oct 17, 2024 |
pre | Proxies and info statements | 4 | Oct 15, 2024 |
8-k | 8K-related | 13 | Oct 04, 2024 |
8-k | 8K-related | 13 | Sep 19, 2024 |